Anti-neutrophil cytoplasmic antibodies negative eosinophilic granulomatous polyangiitis glomerulonephritis in children - A diagnostic dilemma by Sharma, Shobha et al.
Vol 5 | Issue 1 | Jan 2018 Indian J Child Health 63
Case Report
Anti-neutrophil cytoplasmic antibodies negative eosinophilic granulomatous 
polyangiitis glomerulonephritis in children - A diagnostic dilemma
Shobha Sharma1, Suprita Kalra2, Aditi Sinha3, Arvind Bagga4
From 1Department of Pediatrics and Pediatric Nephrology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India, 
2Department of Pediatrics and Pediatric Nephrology, Command Hospital and AFMC, Pune, Maharashtra, India, 3Depatments of Pediatrics and 
Pediatric Nephrology and 4Division of Pediatric Nephrology, All India Institutes of Medical Sciences, New Delhi, India
Correspondence to: Dr. Shobha Sharma, Department of Pediatrics and Pediatric Nephrology, Vardhman Mahavir Medical College and 
Safdarjung Hospital, New Delhi, India. E-mail: oum.shobha76@gmail.com
Received - 02 November 2017 Initial Review - 02 December 2017 Published Online - 19 January 2018
Anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitis (AAV) refers to small-to-medium vessel vasculitis with multisystemic involvement and 
is characterized by the presence of ANCA to specifically either 
proteinase-3 (PR3) or myeloperoxidase (MPO). Absence or 
paucity of immune complex deposits in vessel walls is very 
characteristic; hence, the name “Pauci-immune vasculitis.” 
Kidneys are one of the primary target organs typically 
presenting with pauci-immune focal and segmental necrotizing 
and crescentic glomerulonephritis. Diagnosis is based on a set 
of clinical, laboratory, and histological criteria. Eosinophilic 
granulomatous polyangiitis (EGPA) earlier called Churg-Strauss 
vasculitis (CSS) is a granulomatous necrotizing vasculitis of small 
and medium-sized vessels that primarily affects individuals with 
severe asthma or allergies. It has been reported extremely rarely 
in pediatric population its exact incidence not known. It is one of 
the clinicopathological variants of AAV, others being microscopic 
polyangiitis, granulomatosis with polyangiitis (Wegener’s), 
and single-organ AAV (e.g., renal-limited AAV). All these are 
characterized by the presence of ANCA in varying proportions.
Kidney involvement in EGPA is typically in the form of 
necrotizing eosinophilic glomerulonephritis. Due to the rarity of 
the condition in children pediatric-specific criteria for EGPA have 
not been formulated so far [1]. Rarer still is the ANCA negative 
vasculitis which has the similar clinical and histopathological 
features but undetectable ANCA autoantibodies [2]. We report 
a 9-year-old boy who presented with rapidly proliferative 
glomerulonephritis with eosinophilia with pauci-immune 
crescentic picture on kidney biopsy.
CASE REPORT
A 9-year-old boy presented with complaints of passing tea 
colored urine and facial puffiness for 5–6 days. Child also had 
a history of non-productive cough since past 10–15 days. There 
was no significant history of fever, decreased urine output, rash, 
joint pains, or intake of any medication. Parents gave a history 
of recurrent cough in the past but no history of nebulization or 
any regular bronchodilator inhalation therapy. On admission; child 
was hypertensive (blood pressure [BP] 143/100 mm-Hg) with mild 
periorbital puffiness and pedal edema. He had no pallor, icterus, 
and petechial rash; clubbing or lymphadenopathy. Respiratory 
system examination revealed rhonchi all over the chest. Rest of 
the systemic examination was essentially normal. Provisional 
diagnosis of glomerulonephritis with acute exacerbation of 
bronchial asthma was made, and the patient was evaluated further.
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Urine microscopic examination showed numerous 
red blood cells (RBCs), and RBC casts with 3+ proteins on 
the dipstick and 24 h total urine protein was 7645 mg. He had 
mild anemia (hemoglobin 9.6g%) and normal platelet count 
(290,000/ mm3) but repeatedly high leukocyte counts (maximum of 
58,200 cells/mm3) with increased eosinophils (maximum absolute 
eosinophil count [AEC] of 40,158 cells/mm3). Peripheral smear 
revealed abundant eosinophils. The serum urea was 214 mg/ dl 
and creatinine 7.8 mg/dl. Serum C3 was normal (94 mg/dl). 
ANA was negative. ANCA reports done with ELISA and IF were 
negative. IgE levels (1515 IU/ml) were found to be elevated. CRP 
(9.5 mg/ dl) and ESR (102 mm in the 1st hour) were also elevated. 
X-ray chest was essentially normal except for mild hyperinflation.
In view of worsening kidney function child was started on 
intermittent hemodialysis with supportive treatment including 
antihypertensive agents. After 48 h, renal biopsy was done 
(Fig. 1). Light microscopy showed cellular crescents in 8 out of 
16  glomeruli with marked endocapillary proliferation; neutrophilic 
infiltrates and tuft necrosis. A non-necrotizing granuloma was 
also seen in the interstitium with dense inflammatory infiltration 
of eosinophiles. Immunofluorescence showed minimal capillary 
wall deposits of Immunoglobulin M (IgM) and C3 with otherwise 
no staining of immune complexes suggestive of pauci-immune 
crescentic glomerulonephritis. Biopsy of the overlying skin and 
subcutaneous tissue showed dense eosinophilic infiltration. The 
patient was given 3 intravenous pulses of methylprednisolone. 
7 sessions of double volume plasma exchange were also done 
in view of dialysis dependence and severe azotemia. Following 
this, the total leukocyte count dropped significantly to the range 
of 9000–12,000 cells/mm3 with AEC of <200 cell/mm3 tested on 
multiple occasions. Kidney functions improved gradually over next 
10 days to serum creatinine of 0.5 mg/dl and good urine output.
Final diagnosis of ANCA negative EGPA with pauci- immune 
necrotizing crescentic GN was made. The child was also given 6 
intravenous pulses of cyclophosphamide at a dose of 500 mg/ m2 
every 3 weeks as part of induction therapy after ruling out any 
active infection and under strict monitoring for fall in total 
leukocyte count followed by 750 mg/m2 of oral mycophenolate 
mofetil. He is under regular follow-up and has good urine output 
with normal blood pressure, AEC, and renal functions. However, 
he continues to have subnephrotic proteinuria (400–500 mg/m2) 
for which 0.3 mg/kg/day of oral enalapril has been added with 
2 week monitoring of serum creatinine and potassium levels.
DISCUSSION
EGPA earlier known as CSS is a multisystem small vessel vasculitis 
seen in association with ANCA specific for MPO- ANCA or 
PR3-ANCA or maybe ANCA negative. This condition is rare in 
childhood population. Chapel Hill Consensus Conference-2012 
defines EGPA as necrotizing vasculitis involving small-to-
medium vessels with no or minimal immune deposits [3]. EGPA 
is eosinophil-rich necrotizing granulomatous inflammation of 
small-to-medium vessels often associated asthma and respiratory 
symptoms. ANCA is more frequently detected when renal 
involvement (glomerulonephritis) is present. The prominence of 
eosinophils in blood and tissues is an essential feature of EGPA 
and hence the name. Although it is observed that in adults about 
25% of patients with EGPA without renal disease are ANCA 
positive, whereas with any renal disease and in those with 
documented necrotizing glomerulonephritis ANCA positivity is 
seen in 75% and 100% cases, respectively [4].
Etiopathogenesis of EGPA remains unclear, evidence suggests 
genetic predisposition, which may include inherited a tendency 
of deregulation of cellular immune system. Recent studies have 
demonstrated primary genetic causes for hypereosinophilia [5,6]. 
ANCA negative AAV is also a well-recognized entity, where 
inpatient otherwise fulfills the definition for an AAV but has 
negative results on serologic testing for ANCA. Patients with 
ANCA-negative AAV may have ANCA that cannot be detected with 
current methods or may have ANCA of undiscovered specificity, 
or pathogenic mechanisms that involve the antibodies like human 
lysosome-associated membrane protein-2 (hLAMP- 2) that bind 
to the glomerular, but not the neutrophil hLAMP-2 antigen and 
found in patients with active vasculitis who are negative for PR3 
or MPO. Kain et al. proposed evidence of molecular mimicry 
between LAMP2 and Fim-H bacterial protein which indicates the 
role of bacterial infection [7].
Diagnosing EGPA in pediatrics is difficult since all the defined 
criteria may not be present at the time of presentation in children. 
Moreover, ANCA positivity in pediatric population is found 
to be very low (25%) [8]. Razenberg et al. reported CSS in a 
12-year-old boy with asthma and peripheral as well as pulmonary 
eosinophilia and was ANCA negative [9]. The American College 
of Rheumatology proposed 6 criteria for the Charge-Strauss 
syndrome: Asthma, peripheral blood eosinophilia (more than 
10% on differential white blood cell count), mononeuropathy or 
polyneuropathy, non-fixed pulmonary infiltrates, paranasal sinus 
abnormalities, and extravascular eosinophilia [10]. The presence 
of 4 or more of these has sensitivity of 85% and specificity of 
99.7%. Histologically, there is a typical triad of necrotizing 
vasculitis, granulomas, and extravascular eosinophilia [8].
Another unusual feature in our case was the absence of long 
insidious onset and absence of predominant respiratory symptoms 
including asthma. In pediatric case series by Zwerina et al. the 
most common features reported were asthma (91%), pulmonary 
infiltrates (85%), sinusitis (77%), skin involvement (66%), cardiac 
disease (55%), gastrointestinal symptoms (40%), peripheral 
neuropathy (39%), and kidney disease (16%) [8]. ANCA was 
Figure 1: Photomicrograph of the renal biopsy showing eosinophilic 
vasculitis with crescent formation
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found to be positive in 23% cases. In our child, ANCA was 
negative despite severe involvement of kidney, but histologically, 
all the three components of triad were present. Other conditions 
are leading to peripheral and tissue eosinophilia such as HES, 
infection-induced, allergy or atopy, drug-induced, and neoplastic 
conditions were also considered and ruled out by history and 
relevant investigations. Presence of crescentic necrotizing 
glomerulonephritis with eosinophilic infiltration and granulomas 
in renal biopsy is highly specific for EGPA and virtually rules out 
conditions like interstitial nephritis.
There are no definitive guidelines for immune-suppressive 
treatment in EGPA. Gayraud et al. from French Vasculitis study 
group presented data on the long-term follow-up of 278 patients 
with PAN and CSS enrolled in 4 prospective trials between 1980 
and 1993 and reported improved renal survival with combined use 
of corticosteroid and cyclophosphamide in patients with severe 
vasculitis renal involvement [11]. In our patient, we did induction 
therapy with IV methyl prednisolone and IV cyclophosphamide. In 
view of severe renal involvement, we also did plasma exchanges 
(7 in number) and same is endorsed by various studies. Although 
mechanism for improvement of renal functions is thought to 
be removal of pathogenic ANCA, additional mechanism by 
removal of cytokines and coagulation factors have also been 
hypothesized [12- 14]. Jayne et al. in Randomized controlled trial 
on using pulse methyl prednisolone or plasma exchanges in addition 
to oral steroids and cyclophosphamide (MEPEX) showed increased 
efficacy with plasma exchange in acute stage [15]. Our patient 
had severe renal involvement with very high creatinine values, 
oligoanuria as well as severe histological changes (100% crescents) 
but showed benefit from aggressive initial therapy (high dose 
IV MP and IV cyclophosphamide with Plasma exchanges).
CONCLUSION
EGPA diagnosis in children is difficult with varied presentation 
and lack of diagnostic tests. Kidney involvement is one of the 
severest manifestations and has a poor outcome if not detected 
and treated early. High index of suspicion is the key to diagnosis 
in the presence of compatible clinical picture.
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